Happy Patient Safety Awareness Week from IRRAS! With an estimated 134 million adverse events occurring yearly due to unsafe care, the work we do to create safe, reliable, and effective medical devices has never been more important. Our commitment to developing technology that reduces errors and improves patient outcomes is at the core of what we do. Let's unite to continue advancing patient safety, making healthcare safer for everyone, everywhere.?
IRRAS USA Inc.
医疗设备制造业
San Diego，California 4,341 位关注者
Bringing Needed Innovation to Neurocritical Care
关于我们
IRRAS is a privately-held commercial medical device company that develops and commercializes innovative solutions that are designed to transform neurocritical care. Our initial clinical focus is on neurosurgical procedures, where excess cerebrospinal fluid (CSF) or toxic blood byproducts often need to be emergently drained and intracranial pressure (ICP) needs to be closely regulated. IRRAS’ first commercial product, IRRAflow?, is a next-generation intracranial fluid management system that consists of a patented dual lumen catheter, intelligent cassette, and control unit with proprietary software that work together to manage the drainage of excess fluid, intelligently regulate the patient’s ICP, and, on a regular basis, proactively flush the catheter to enable active fluid exchange. These catheter blockages occur more than 40% of the time1 with legacy passive drainage systems and can result in inefficient drainage and excessively high infection rates.2 IRRAflow’s combination of recurring irrigation, controlled drainage, and continuous patient monitoring active addresses these shortcomings and provides a new standard of care for how patients in the neurosurgical intensive care unit are managed. Through continued technological advances, IRRAS remains focused on developing innovative features for IRRAflow as well as new products and applications based on our core fluid exchange technologies. In the future, we envision new therapeutic applications for the IRRAflow platform, including targeted drug delivery and drainage in other clinical areas. IRRAS is headquartered in San Diego, California
- 网站
-
https://www.irras.com
IRRAS USA Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- San Diego，California
- 类型
- 私人持股
地点
IRRAS USA Inc.员工
动态
-
The #IRRAS team is attending Northwestern Medicine’s ICH Workshop later this month! Led by Dr. Babak Jahromi, the workshop will dive into ICH management strategies, hands-on instruction and a reveal of the ARCH Trial interim results.? ? Be sure to register using the QR code below – we'll see you there!
-
-
We're #hiring a new Global Training and Education Manager in San Diego, California. Apply today or share this post with your network.
-
The University of New Mexico’s 2024 case-control study demonstrates the clear advantage of IRRAflow for intraventricular hemorrhage treatment:? ? 0% of IRRAflow patients required shunt placement versus 15% of EVD patients? ? 2.5 days to ventricular clearance with IRRAflow versus 5.8 days with standard EVD? ? 86% of IRRAflow patients achieved good outcome (mRS≤3) at 90 days versus 37% of EVD patients?? ? The data speaks for itself – IRRAflow is transforming care in the neurocritical space. Learn more at the link below: https://lnkd.in/dZwBh3K6
-
Our #IRRAflowFamily is on-the-move! Whether we’re running into each other by happenstance or teaming up to make change in the field, the IRRAflow commercial team is dedicated to 24/7 support for our users across the country. Smiles courtesy of Mollie Brown, BSN, RN and Denisha Pittman!
-
-
We are excited to be a part of the conversation at the International Stroke Conference in Los Angeles! Advancing stroke care is at the core of our mission, and we’re looking forward to discovering the latest innovations in the field. Will you be there? Click the link below to schedule a meeting with our IRRAS team - we'd love to connect! https://lnkd.in/gPmicjYS
-
Dr. Jahromi’s educational presentation at #ANIMBerlin is today! Head to the IRRAflow booth to join in on the discussion.
-
-
Don’t miss Dr. Jahromi’s presentation tomorrow at #ANIMBerlin! Tune in to learn more about his experience with IRRAflow within the ARCH Trial.
-